You are here: Industry Insights > cancer

News List

Novartis & Bristol-Myers Squibb to collaborate on cancer treatments europeanpharmaceuticalreview
May 07, 2019
Novartis has entered into a research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist…
New imaging technique may predict the spread of breast cancer europeanpharmaceuticalreview
May 06, 2019
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung…
Z-endoxifen shows promise for breast cancer europeanpharmaceuticalreview
May 06, 2019
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer…
Good news for AZ's 'next phase of growth': Its cancer drugs have shifted into high gear fiercepharma
May 06, 2019
For the first time, AstraZeneca's top-selling medicine isn't a stomach drug or a respiratory inhaler or any other primary care med. It's a cancer drug.
MRI effective in detecting postpartum breast cancers europeanpharmaceuticalreview
May 06, 2019
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI…
ALA-artemisinin combination therapy for cancer identified europeanpharmaceuticalreview
May 06, 2019
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…
TK216-vincristine combination for Ewing sarcoma identified europeanpharmaceuticalreview
May 06, 2019
TK216-vincristine combination appears to halt the ability of Ewing sarcoma to grow and progress…
PI3K inhibitors show hope for rare bone cancers europeanpharmaceuticalreview
May 06, 2019
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma…
Neratinib defeats the Ras genes notorious for causing cancer europeanpharmaceuticalreview
May 06, 2019
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development…
AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer drugs
May 06, 2019
Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page